ABBOTT LABORATORIES (ABT) Stock Price, Quote, News and Overview
NYSE:ABT - New York Stock Exchange, Inc. - US0028241000 - Common Stock - Currency: USD
ABT Quote, Performance and Key Statistics
ABBOTT LABORATORIES
NYSE:ABT (1/29/2025, 8:04:00 PM)
After market: 128.5 +0.64 (+0.5%)127.86
+0.47 (+0.37%)
The current stock price of ABT is 127.86 USD. In the past month the price increased by 11.19%. In the past year, price increased by 14.05%.
ABT Latest News, Press Releases and Analysis
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.
These S&P500 stocks are moving in today's session
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Wednesday's session.
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Abbott Laboratories Will Outperform Healthcare Stocks in 2025
Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.
My Top 5 Stocks to Buy in Early 2025
ABT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 78.13 | 203.99B | ||
| BSX | BOSTON SCIENTIFIC CORP | 43.52 | 151.38B | ||
| SYK | STRYKER CORP | 32.08 | 149.08B | ||
| MDT | MEDTRONIC PLC | 17.41 | 117.21B | ||
| BDX | BECTON DICKINSON AND CO | 18.76 | 71.60B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.64 | 41.95B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.82 | 40.14B | ||
| RMD | RESMED INC | 30.5 | 37.12B | ||
| IDXX | IDEXX LABORATORIES INC | 38.24 | 34.29B | ||
| DXCM | DEXCOM INC | 50.84 | 33.76B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 20.36 | 25.64B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 14.07 | 22.11B |
Related stock screener links
About ABT
Company Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The firm is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The firm operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.
Company Info
ABBOTT LABORATORIES
100 Abbott Park Road, Abbot Park
ABBOTT PARK ILLINOIS 60064 US
CEO: Robert B. Ford
Employees: 114000
Company Website: https://www.abbott.com
Investor Relations: https://www.abbott.com/investors.html
Phone: 12246676100
ABT FAQ
What is the stock price of ABT?
The current stock price of ABT is 127.86 USD.
What is the symbol for ABBOTT LABORATORIES stock?
The exchange symbol of ABBOTT LABORATORIES is ABT and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is ABT stock listed?
ABT stock is listed on the New York Stock Exchange, Inc. exchange.
Is ABT a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ABT, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ABT.
Does ABT stock pay dividends?
ABT has a dividend yield of 1.85%. The yearly dividend amount is currently 2.05.
What is the Price/Earnings (PE) ratio of ABT?
The PE ratio for ABT is 27.38. This is based on the reported non-GAAP earnings per share of 4.67 and the current share price of 127.86 USD.
What is the Short Interest ratio of ABT stock?
The outstanding short interest for ABT is 0.83% of its float.
ABT Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ABT. When comparing the yearly performance of all stocks, ABT turns out to be only a medium performer in the overall market: it outperformed 69.54% of all stocks.
ABT Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ABT. While ABT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
ABT Financial Highlights
Over the last trailing twelve months ABT reported a non-GAAP Earnings per Share(EPS) of 4.67. The EPS increased by 5.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.99% | ||
| ROA | 7.76% | ||
| ROE | 14.49% | ||
| Debt/Equity | 0.32 |
ABT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 81% to ABT. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of 11.38% and a revenue growth 7.06% for ABT